These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10741019)

  • 1. [Reduced endothelial function is hardly a cause of primary Raynaud's phenomenon. Alternative mechanisms should be studied to clarify the causes].
    Hedenstierna G
    Lakartidningen; 2000 Feb; 97(8):812-3. PubMed ID: 10741019
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of Raynaud's disease.
    Cooke JP; Marshall JM
    Vasc Med; 2005 Nov; 10(4):293-307. PubMed ID: 16444858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma.
    Freedman RR; Girgis R; Mayes MD
    J Rheumatol; 1999 Nov; 26(11):2386-8. PubMed ID: 10555897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raynaud's phenomenon: clinical aspects of the disease].
    Konychev AV; Koreshkina TA; Kokorin KV; Kaiukov AV
    Vestn Khir Im I I Grek; 2001; 160(2):118-22. PubMed ID: 11496483
    [No Abstract]   [Full Text] [Related]  

  • 6. L-arginine therapy in Raynaud's phenomenon?
    Agostoni A; Marasini B; Biondi ML; Bassani C; Cazzaniga A; Bottasso B; Cugno M
    Int J Clin Lab Res; 1991; 21(2):202-3. PubMed ID: 1815764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local hyperemia to heating is impaired in secondary Raynaud's phenomenon.
    Boignard A; Salvat-Melis M; Carpentier PH; Minson CT; Grange L; Duc C; Sarrot-Reynauld F; Cracowski JL
    Arthritis Res Ther; 2005; 7(5):R1103-12. PubMed ID: 16207327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral analysis of laser-Doppler perfusion signal measured during thermal test.
    Maniewski R; Leger P; Lewandowski P; Liebert A; Bendayan P; Boccalon H; Bajorski L; Möller KO
    Technol Health Care; 1999; 7(2-3):163-9. PubMed ID: 10463305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear and nonlinear analysis of blood flow in healthy subjects and in subjects with Raynaud's phenomenon.
    Stefanovska A; Leger P; Bracic M; Bracic T; Bendayan P; Boccalon H
    Technol Health Care; 1999; 7(2-3):225-41. PubMed ID: 10463311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local cooling test for clinical capillaroscopy in Raynaud's phenomenon.
    Mahler F; Saner H
    Vasa Suppl; 1989; 27():27-8. PubMed ID: 2623512
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endothelin-1 in pathogenesis of Raynaud's syndrome].
    Knapik-Kordecka M; Adamiec R; Ciosek W
    Pol Merkur Lekarski; 2001 Jun; 10(60):424-5. PubMed ID: 11503255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum endothelin in patients with Raynaud syndrome before and following cold provocation].
    von Bierbrauer A; Herzog U; Ehlenz K; Wichert P
    Vasa Suppl; 1991; 33():156-7. PubMed ID: 1788654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic characteristics of laser-Doppler flux in normal individuals and patients with Raynaud's phenomenon before and after treatment with nifedipine under different thermal conditions.
    Popivanov D; Mineva A; Bendayan P; Leger P; Boccalon H; Möller KO
    Technol Health Care; 1999; 7(2-3):193-203. PubMed ID: 10463308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Definition and epidemiology of vascular acrosyndromes].
    Carpentier PH
    Rev Prat; 1998 Oct; 48(15):1641-6. PubMed ID: 9814064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathology of Raynaud's phenomenon].
    Bollinger A
    Dtsch Med Wochenschr; 1982 Nov; 107(45):1699-701. PubMed ID: 7140547
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physiopathogenic study of so-called Raynaud's phenomenon (author's transl)].
    Merlen JF; Langeron P; Croccel L
    J Mal Vasc; 1981; 6(4):269-72. PubMed ID: 7320643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Raynaud's disease and Raynaud's phenomenon in connective tissue diseases].
    Sicińska J; Rudnicka L
    Pol Arch Med Wewn; 2002 Oct; 108(4):1011-22. PubMed ID: 12642947
    [No Abstract]   [Full Text] [Related]  

  • 20. Estrogens and neuropeptides in Raynaud's phenomenon.
    Generini S; Seibold JR; Matucci-Cerinic M
    Rheum Dis Clin North Am; 2005 Feb; 31(1):177-86, x-xi. PubMed ID: 15639062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.